^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    RPM CD19-mbIL15-CAR-T cells

    i
    Other names: RPM CD19-mbIL15-CAR-T cells, CAR CD19 3rd gen CAR with mbIL15 (P-O-C), CD19-mbIL15-chimeric antigen receptor [CAR]-T cells, CAR CD19 3rd gen CAR with mbIL15 (Point of care), P-O-C CD19-mbIL15-chimeric antigen receptor [CAR]-T cells, autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-EGFRt T cells, CD19-CD8CD28zCAR-specific-mbIL15-HER1t T lymphocytes, autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T cells, CD19+ specific chimeric antigen receptor T cells, CD19-specific T cells expressing membrane-bound form of IL-15, CD19RCD28
    Associations
    News
    Trials
    Company:
    Alaunos Therap, Eden BioCell, UT MD Anderson Cancer Center
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials